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Center for Blistering Diseases, Department of Dermatology, 






The Center for Blistering Diseases in Groningen is the expertise center for acquired and hereditary 
blistering diseases in the Netherlands. Considering the hereditary blistering diseases this has 
accumulated in a database consisting of 248 unrelated probands/families with a skin fragility 
genodermatosis on October 1st, 2009. The majority of these cases have a form of epidermolysis 
bullosa (EB). EB is a group of hereditary skin blistering diseases (bullous genodermatoses), 
characterized by blistering and erosions of the skin, and sometimes mucosae, usually present from 
birth or starting within the first few years of life, and remaining throughout life. The knowledge 
about EB and its pathogenesis has increased manifold in the last decades. Observations and 
studies involving the EB population that visited the Center for Blistering Diseases in Groningen 
have added to this knowledge. Fragile epidermal cell cytoskeletons, impaired connections 
between cells within the epidermis, or impaired adhesion of the basal epidermal cells to the 
dermis, caused by defects or even absence of molecules that are important for these functions, 
underlie the different types of EB. Trivial mechanical trauma is sufficient for rupture of these 
fragile connections or cell-cytoskeletons, with subsequent blister formation. Mutations in the 
DNA coding for these molecules are underlying the absence/defects. At present, mutations in 
13 different genes coding for 10 different proteins are known to cause the different forms of EB 
(table 1). In the latest EB consensus (agreed on in Vienna, 2007) four major EB types are defined 
based on the level of blister formation in the skin: intraepidermal for EB simplex (EBS), through 
the lamina lucida in junctional EB (JEB), in the sublamina densa zone in dystrophic EB, and a 
mixed-type level of blister formation in Kindler syndrome (see figure 1 and 2, and table 1).1
Table 1. EB classification according to the latest consensus1




Suprabasal EBS Plakophilin-1; desmoplakin
Basal EBS
Keratin 5 and 14 (rare: plectin, 
integrin α6β4, BP180)




JEB, other Laminin-332, BP180, integrin α6β4
Sub - lamina densa 
(‘dermolytic’)
DEB
Dominant DEB Type VII collagen
Recessive DEB Type VII collagen
Mixed Kindler syndrome - FFH-1 (Kindlin-1)
Considerable insight in functioning of normal tissues and insight in pathogenetic processes has 
been established by studying disease. Pasmooij et al.2, 3 have collected the data of non-Herlitz 
JEB patients with their underlying causal mutations in the proteins type XVII collagen (gene: 
COL17A1) and laminin-332 (genes: LAMA3, LAMB3, LAMC2) that visited the Center for Blistering 
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Diseases in Groningen, whereas van den Akker et al.4 have described the DEB patients with 
mutations in the type VII collagen gene COL7A1.
Figure 1. The levels of blister formation observed in skin of patients with one of the major EB types. In EBS the 
plane of cleavage is intraepidermal (suprabasal or basal). In junctional EB (JEB) the plane of cleavage resides 
within the lamina lucida. In dystrophic EB (DEB) blister formation is beneath the lamina densa (sublamina 
densa), in the dermis. Skin fragility in Kindler syndrome can give rise to various planes of cleavage. Courtesy 
of M.F. Jonkman.
Figure 2. Schematic representation of the hemidesmosome-stable adhesion complex (right) and the focal 
adhesion complex (left). Mutations in the genes encoding the coloured proteins cause the different forms 








The general aim of this thesis was to investigate and refine the genotype-phenotype correlation 
in genodermatoses involving blistering with an intraepidermal plane of cleavage: EBS, by 
studying the data obtained from the EBS patients that visited the Center for Blistering Diseases in 
Groningen between 1989 and present. In the latest EB consensus EBS was subdivided in suprabasal 
and basal EBS (see figure 1 and table 1) and this thesis involves both these subtypes. Basal EBS 
is usually caused by autosomal dominant mutations in the genes KRT5 and KRT14 encoding the 
keratins K5 and K14, respectively, that form the keratin cytoskeleton in basal keratinocytes. The 
mutations impair keratin assembly into a strong filamentous network, thus rendering the cells 
less stress-resistant. Consequently, rupture of the basal cells and intraepidermal blister formation 
appears upon mild mechanical trauma. One of the observations made by studying our database 
was that in 25% of the basal EBS patients no mutation in the genes KRT5 or KRT14 could be found. 
Subsequently an additional aim of this thesis was formulated, namely, to identify the underlying 
genetic defect in a group of basal EBS patients with wildtype KRT5 and KRT14 genes (chapter 2 
and 3). A further goal was to identify the underlying molecular defect in single unusual cases. 
As treatment of the underlying gene and/or protein defect in genodermatoses comes closer to 
reality, identification of the aetiology of genetic diseases becomes more important then ever. 
The currently known forms of suprabasal EBS are caused by mutations in desmosomal proteins, 
some of which are associated with cardiac disease as well: the desmosomal cardiocutaneous 
syndromes.5 Another aim of this thesis was to compare and link the current knowledge in the 
research fields of cardiogenetics and genodermatoses involving similar proteins in cell-cell and 
cell-matrix junctions, to obtain better understanding of the functioning of these proteins, the 
structures they belong to, and disease pathogenesis. 
 Chapter 1 provides a general introduction about the skin and the major cell population 
of the epidermis: the keratinocytes. The different keratinocyte cell-cell and cell-matrix junctions 
are discussed. The desmosome is the major linker of the keratin cytoskeletons of adjacent 
epidermal cells, not only in the epidermis, but also in other stress-bearing tissues, such as the 
myocardium and the intestine. Another important cell-cell junction is the adherens junction 
which anchors the actin skeleton to the cell membrane. The cell-matrix junctions in the skin 
are the hemidesmosome, which anchors the keratins of basal cells to the basement membrane 
zone (BMZ), and the focal adhesion, which anchors the actin cytoskeleton to the BMZ. The 
versatile cytolinker protein plectin is discussed in further detail, as it is subject of investigation 
and discussion in chapter 3, 6 and 7 of this thesis. Plectin is present in hemidesmosomes and 
desmosomes, and is associated with both the intermediate filament cytoskeleton (i.e. keratins, 
desmin) and the actin cytoskeleton. Plectin is expressed in a multitude of tissues, among which 
skin, skeletal muscle, heart, and nerve tissue. Mutations in the gene PLEC1 coding for plectin 
are associated with several different phenotypes which share basal intraepidermal skin fragility 
(EBS) as a common feature. In addition, chapter 1 introduces EB and its latest classification. 
In the light of chapters 2, 3 and 4, the present knowledge about the major component of 
keratinocytes, the keratin intermediate filament protein, and the associated hereditary keratin 
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disorders basal EBS (mutations in KRT5 and KRT14) and epidermolytic ichthyosis (EI, mutations 
in KRT1 and KRT10), is presented. 
 Basal EBS is predominantly caused by autosomal dominant mutations in the genes 
KRT5 and KRT14 encoding the keratins 5 (K5) and 14 (K14), which form the keratin cytoskeleton 
of keratinocytes in the basal epidermal layer. These mutations render the keratin skeleton less 
resistant to mechanical stress. Consequently rupture of the cells and blister formation upon 
trivial mechanical trauma appears. Considerable variation in severity and onset of blistering 
is observed in EBS patients with mutations in KRT5 and KRT14. Three main clinical subtypes 
of basal EBS are defined (figure 3). EBS, localized (EBS-loc) is the mildest form with blistering 
usually confined to hands and feet. The onset of EBS-loc is mostly in infancy when the child 
starts to walk. EBS, Dowling Meara (EBS-DM) is the severest form and characterized by neonatal 
onset of severe generalized grouped ‘herpetiform’ blistering, usually involving oral mucosa 
and subungual skin leading to onycholysis. In the neonatal period this may have even a lethal 
course. The blistering improves after puberty and palmoplantar keratoderma usually develops. 
The essential feature leading to the diagnosis of EBS-DM is clumping or aggregation of keratin 
tonofilaments observed on ultrastructural examination of skin samples of the patient (figure 
3). In between EBS-loc and EBS-DM is EBS, generalized non-DM (EBS-gen) with generalized 
non-herpetiform skin fragility, usually starting in the first weeks to months of life. No keratin 
clumping is seen in skin biopsies of patients with EBS-gen. 
Figure 3. Clinical features in the different subtypes of basal EBS. Upper row from left to right: loc, gen, 
and DM.  Lower row: MP (mottled pigmentation), migr (migratory circinate), and the electron microscopic 
observation of keratin clumping in EBS-DM. 
In chapter 2 the basal EBS patient population that visited the Center for Blistering Diseases of 
our department of Dermatology in Groningen, the Netherlands, since 1989 is described. The 





compared with all previously described KRT5 and KRT14 mutations deducted from PubMed 
(www.ncbi.nlm.nih.gov/pubmed) and the Human Intermediate Filament Database (www.
interfil.org).6 Three main findings are noted: 1) the high percentage of de novo mutations (39%), 
2) a correlation between the location of the mutations within the K5 and K14 proteins and the 
phenotype, and 3) the high percentage (25%) of unrelated, biopsy-proven basal EBS patients 
without mutations in KRT5 and KRT14. The high percentage of de novo mutations, meaning both 
parents did not carry the mutation, may have several reasons we can only speculate about. Non-
paternity may be underlying some of the seemingly de novo mutations. Another possibility is 
germline mosaicism in one of the parents. A third explanation may be that hardly any changes 
in the highly conserved keratins are tolerated and that any change results in disease phenotype. 
Thus the high percentage de novo mutations may reflect a high mutability at this part of the 
human genome during reproduction. 
 The correlation between the genotype and the phenotype confirms previously 
reported correlations in other basal EBS populations. Keratins form obligate heterodimers 
consisting of a type I keratin (such as K14) and a type II keratin (such as K5). A keratin consists 
of a central α-helical rod domain, interrupted by three linker domains and flanked by variable, 
non-helical head and tail domains (figure 4). 
Figure 4. The molecular organization of K5 and K14. K5 and K14 form obligate parallel and in-register 
coiled-coil heterodimers in basal keratinocytes. Keratins consist of a central α-helical rod domain which is 
interrupted by three non-helical linker domains (L1, L12, and L2) giving rise to the four subdomains 1A, 
1B, 1B and 2B. An additional non-helical stretch in subdomain 2B, the stutter (st), interrupts the α-helical 
structure in this subdomain. The variable and non-helical head and tail domains are folded backwards 
supporting the dimer. The figure below is from Hermann et al.7 (with permission).  HIM, helix initiation motif; 
HTM, helix termination motif. 
H1 1B 2A H21A 2B
HIM HTML1 L2 L12
rodhead tail
K14 tail (52)












In the initial steps of keratin assembly the helix boundary motifs at both ends of the keratin 
rod domain play an important role. Mutations affecting these highly conserved helix boundary 
motifs of K5 and K14 cause the severe EBS-DM phenotype, while mutations affecting the more 
central rod domain sequences or the linker domains cause milder EBS-gen and EBS-loc. Mutations 
affecting the variable head and tail domains cause more atypical phenotypes, such as EBS with 
mottled pigmentation and EBS with migratory circinate erythema (figure 3). This correlation 
is, however, not a 1:1 phenomenon and several exceptions were noted. Different mutations 
affecting the same domain, and even the same amino acid, may cause different phenotypes. In 
addition, intrafamilial variation is observed and identical mutations in unrelated patients may 
cause phenotypes of different severity. These findings, in combination with the observations of 
varying blistering severity in summer and winter and improvement during fever periods, and over 
lifetime in general, point to a complex interplay between genetic, epigenetic, and external factors 
in determining eventual clinical outcome. Elucidation of these factors may provide treatment 
opportunities. This is discussed in chapter 2 and in the general discussion in chapter 9. 
 In 25% (16 of 65) of the total number of basal EBS patients in our population no 
mutations could be found in K5 or K14. A similar percentage has been reported for the EBS 
population in the United Kingdom.8 We extended the standard KRT5 and KRT14 mutation 
screening (single exon amplification and direct sequencing) with long range PCR fragment 
length analysis on KRT5 and KRT14 gDNA and cDNA derived from RNA from patient’s fresh frozen 
skin samples. In addition, we looked for K5 and K14 protein expression by immunofluorescence 
analysis of patient’s skin biopsies to exclude recessive loss-of-protein mutations in the sporadic 
cases. The negative findings in these additional studies render mutations that may be missed 
with the regular mutation screening unlikely. Examples of mutations that may be missed with 
the regular mutation screening are heterozygous larger in-frame deletions and insertions, 
and heterozygous/homozygous intronic mutations that affect splicing. Altogether these data 
suggest genetic heterogeneity for basal EBS. Alternatively, epigenetic processes influencing 
K5 or K14 expression/functioning may be underlying these cases. Other possibilities are copy 
number variations of the complete KRT5 or KRT14 genes, or complex recombinations.
 In chapter 3 one possible explanation for the KRT5/KRT14 mutation-negative basal EBS 
observed in chapter 2 is further investigated: genetic heterogeneity. The results of the mutation 
analysis of one of the possible gene candidates, PLEC1, in the KRT5/KRT14 mutation-negative EBS 
cases are presented. In four of 16 (25%) unrelated basal EBS probands with wildtype KRT5 and 
KRT14 genes heterozygous plectin missense mutations were found. Exclusion of the mutations 
in >150 matched control DNA samples, absence of the mutations in the NCBI SNP database, and 
(when possible) confirmation of segregation of the mutation with the phenotype within the 
family, strongly suggest pathogenicity of these mutations. PLEC1 mutations are underlying 6% 
of the total of non-syndromic basal EBS in our population. These data implicate that mutation 
screening of the PLEC1-gene in basal EBS patients lacking mutations in the KRT5 and KRT14 
genes is warranted. 
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 In chapter 4 the pathogenecity of non-helical linker domain L12 mutations in the 
suprabasal keratin K1 is investigated by means of transfection studies. A novel KRT1 mutation, 
p.Asp340Gly, located in the linker L12 domain of K1, was found in three, initially thought to 
be unrelated Dutch families from different parts of the country. Only one mutation had been 
reported in a linker domain of K1 before (p.Asp340Val).9 No mutations have been reported yet 
for one of the linker domains of K10, the other suprabasal keratin and heterodimer-partner of K1. 
Affected persons in the three Dutch families showed an unusual, mild EI phenotype consisting of 
mainly palmoplantar keratoderma and skin blistering. The characteristic neonatal erythroderma 
and generalized hyperkeratosis observed in classical EI were lacking. Initially a novel form of 
suprabasal EBS was suspected, but electron microscopic analysis revealed suprabasal cell 
vacuolisation in one of the patients’ skin samples and, although no keratin clumping was 
observed, this finding raised the suspicion for EI. Of note, the phenotype was very similar to 
the phenotype of the patients with the other, previously reported K1 L12 domain mutation. 
The role of the keratin linker domains in keratin assembly and their function in general, is not 
well understood. We performed transfection studies with the novel mutation (Asp340Gly) and 
the previously reported mutation (Asp340Val) in K1 L12, and subsequently subjected a part of 
the transfected cells to a hypo-osmotic stimulus to investigate the effects of the mutations on 
the keratin skeleton and its stress resistance. Asp340Gly and Asp340Val transfected cells were 
compared to each other, and to wild type K1 transfected cells. Transfection with either one of the 
mutations resulted in abnormal keratin skeletons with keratin aggregations, when compared to 
cells transfected with wild type K1. This effect was aggravated upon application of the stress 
stimulus. No differences were observed between Asp340Gly and Asp340Val transfected cells. 
These data support the pathogenecity of K1 L12 domain mutations in vitro, and point to a role 
of the K1 L12 in normal keratin assembly and/or maintenance of cytoskeleton integrity. In vivo, 
these mutations are associated with a milder EI phenotype with pronounced PPK, and without 
neonatal erythroderma and scaling. Haplotyping and genealogical studies were performed in 
the three families with the novel K1 L12 domain mutation, p.Asp340Gly, and revealed a common 
founder for two families around 1800. SNPs within KRT1 were shared by the third family, 
indicating a common ancestor for the third family as well, although this could not be confirmed 
by genealogical investigation limited to the beginning of the 18th century. However, a common 
ancestor before 1700 is likely. This study strongly indicates that mutations in the linker domain 
of K1 are pathogenetic and tend to be associated with a milder, atypical EI phenotype in which 
clinical features of palmoplantar keratoderma and the skin fragility predominate, and the for EI 
characteristic neonatal erythroderma and development of hyperkeratotic scaling are lacking.
 In chapter 5 we describe an exceptional case of Kindler syndrome with a novel 
mutation in FERMT1 encoding the focal adhesion protein fermitin family homologue-1 (FFH-1, 
formerly called Kindlin-1). This particular patient is the oldest patient with Kindler syndrome 
described thus far, and the course of the disease in this patient provides prognostic information 
about aging with this disease for younger Kindler syndrome patients. However, several clinical 
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features in this patient, such as slight mental retardation, cardiac ventricular hypertrophy with 
ECG abnormalities, and skeletal deformities, were unusual to Kindler syndrome considering 
the expression pattern of FFH-1. Additional array comparative genomic hybridisation (aCGH) 
analysis of patient’s DNA revealed that these features may represent gene contingency. A large ~ 
3 megabases (Mb) deletion of the short arm of chromosome 20 (20p12.3), that involved several 
other genes in addition to FERMT1 gene, was detected heterozygously. Thus the patient was 
compound heterozygous for FFH-1 loss-of-function. Among the deleted genes were cardiac 
expressed genes, such as BMP2 and CRLS1, of which BMP2 is important for bone morphogenesis 
as well. Heterozygous deletion of these genes may thus be involved in the bone deformities 
and the cardiac hypertrophy in the reported patient. The data in this study indicate that it 
may be worthwhile to perform aCGH studies in other Kindler syndrome cases described who 
also showed clinical features not explainable by expression of FERMT1, and more generally: in 
homozygous patients with monogenic disorders and additional unexplainable clinical features, 
to exclude heterozygous larger genomic deletions involving more genes that might be missed 
with regular single gene mutation screening techniques. The other heterozygously deleted genes 
were, as far as is currently known, not expressed in the skin. Therefore, the skin and mucosal 
abnormalities in our patient likely reflect FFH-1 loss-of-function. Additional immunofluorescence 
and ultrastructural analysis of a skin biopsy of the patient showed atrophy and a widened and 
interrupted BMZ. Focal adhesion proteins, as well as hemidesmosomal proteins, showed abnormal 
expression patterns. The integrins α3, α6, and β4 were markedly reduced. Ultrastructurally, 
hemidesmosomes also had a hypoplastic appearance. These data point to an important role 
for FFH-1 in BMZ organisation. Although yet highly speculative, the effects of mutated and/or 
reduced FFH-1 on expression and functioning of integrins may be involved in the increased risk 
of developing squamous cell carcinomas in Kindler syndrome patients. 
Figure 5. Immunofluorescence microscopic (lateral) and ultrastructural views (middle) of the desmosomal 
structures in the epidermis (left) and the myocardium (right). Most left picture is from Green et al.10, and 
the second picture from the left is from Franke et al.11 (both with permission). The two pictures on the right 





 Chapter 6 contains an overview of the current knowledge concerning the cell 
membrane structures that anchor the IF-skeletons of adjacent cells: the desmosomes.5 This 
particular structure is remarkably similar in skin and heart (figure 5). Mutations in the genes 
coding for proteins that are expressed in both epidermal and myocardial desmosomes may 
cause defects in both tissues, thus giving rise to disease affecting skin and heart: the desmosomal 
cardiocutaneous syndromes (DCCS) (figure 6). Examples of DCCS are Carvajal syndrome, Naxos 
disease and Naxos-like syndrome due to mutations in the desmosomal proteins desmoplakin 
(DP), plakoglobin, and desmocollin-2. The clinical features and pathogenesis of the DCCS and 
other hereditary desmosomal diseases are discussed in chapter 6. In this review the functions 
of desmosomes beyond cell-cell adhesion are addressed, followed by a discussion about the 
future perspectives involving research in hereditary desmosomal diseases. Recent studies 
suggest an important role for cell signalling pathways, such as the canonical and well-conserved 
Wnt/β-catenin pathway, in the pathogenesis of the DCCS and desmosomal disease in general. 
These findings may have consequences for the future as they may lead to novel therapeutic 
approaches.
Figure 6. Schematic representation of the desmosome and the adherens junction. On the left side the 
desmosomal proteins expressed in the epidermis are depicted, and on the right side the desmosomal 
proteins in myocardium are depicted. DCCS, desmosomal cardiocutaneous syndrome; DP, desmoplakin; EC, 




































shared by epidermis and myocardium, not associated with DCCS (yet)
242
Summary
Chapter 7 contains the results of tissue studies on skin, skeletal muscle and heart of a patient 
with a cardiocutaneous syndrome due to compound heterozygous mutations in PLEC1 coding 
for plectin. The phenotype of the patient consisted of mild basal EBS present from birth, and 
muscular dystrophy and biventricular dilated cardiomyopathy with ECG abnormalities from his 
thirties. Plectin is not only present in hemidesmosomes, but has been localized to desmosomes 
as well. Therefore, by definition the patient presented in chapter 7 has a DCCS as well. The 
compound heterozygous plectin mutations consisted of a nonsense mutation on the maternal 
allele that resulted in loss of plectin expression as indicated by additional RNA analysis and 
western blotting of patient’s keratinocyte extracts. The mutation on the paternal allele was a 
missense mutation in the plectin N-terminus, which is involved in binding to BP180 and integrin 
β4 in hemidesmosomes, but also in actin binding, and binding to several costameric (cell-matrix 
structure, homologue to hemidesmosome) proteins in skeletal and cardiac muscle.12, 13 Electron 
microscopy and immunofluorescence analysis of skin, skeletal muscle and myocardium revealed 
disrupted binding structures, and altered and diminished expression patterns of plectin binding 
proteins in skin, skeletal muscle and heart. This study is the first to reveal plectin in human 
heart and investigate the effects of plectin mutations on myocardium in humans. The findings 
underscore the importance of plectin for maintenance of cardiac integrity in humans. 
 Chapter 8 includes the description of two related cases with a recently discovered 
form of suprabasal EBS: lethal acantholytic EB (LAEB). This is only the second description of LAEB. 
The results of the mutation analysis in these cases confirm mutations in the gene DSP encoding 
the desmosomal plakin protein DP as the aetiology of LAEB. The detected homozygous 5 bp 
deletion in DSP is predicted to cause truncation of both the rod domain and the C-terminus 
of DP. The latter is important for keratin anchorage to the desmosomal plaque. The compound 
heterozygous DSP mutations in the previously reported LAEB case caused truncation of the DP 
C-terminus and resulted in loss of keratin insertion in otherwise normal appearing desmosomes 
containing a well-defined inner and outer dense plaque.14 Electron microscopy of skin samples 
of the novel LAEB cases with (likely) truncation of both the rod and the C-terminus of DP, revealed 
similar absence of keratin filament insertion. However, an additional absence of desmosomal 
inner dense plaques was observed. These data indicate that the rod domain of DP forms the 
desmosomal inner dense plaque, a notion that is supported by observations in epidermis of 
DP-knockout mice. A further interesting observation in the cases presented in chapter 8 was 
the intrauterine dilated heart. In conjunction with the cardiac abnormalities observed in the 
previously reported LAEB case, these data suggest that LAEB belongs to the group of DCCSs as 
well.  
 Chapter 9 contains the synopsis of the results of the above mentioned studies and the 
general discussion about their implications with ideas for future research. For example, 12 more 
patients/families with basal EBS remain in which we did not find KRT5, KRT14, or PLEC1 mutations, 
despite extensive gDNA, cDNA and protein analyses. Another gene candidate for involvement 
in EBS that will be screened in the near future is the BP230-gene. BP230 is a cytoplasmatic 
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hemidesmosomal protein that belongs to the same plakin protein family as plectin and has a 
similar protein structure. Furthermore, in families with multiple affected persons linkage analysis 
will be performed to search for the locus of the underlying genetic defect. As the research 
fields concerning protein, cell, and gene therapy are rapidly making progress, the discovery 
of the underlying genetic defect in hereditary diseases becomes more important then ever. 
Another (currently running) study initiated by the research presented in this thesis involves the 
collaboration between the departments of Genetics, Cardiology, Pathology and Dermatology 
(Groningen, the Netherlands) in performing a PLEC1 mutation analysis in a group of patients 
with the hereditary cardiac disease arrhythmogenic right ventricular cardiomyopathy (ARVC). 
ARVC is characterized by fibrofatty replacement of myocardial tissue, conduction disturbances 
(visible on an ECG), heart failure and sometimes sudden cardiac death. The word ‘right’ in the 
definition ARVC should not be given too much value as additional left-sided cardiac involvement 
is often present, and may even be the sole disease manifestation. ARVC is considered to be a 
hereditary desmosomal disease, because the majority of causal mutations affect genes encoding 
desmosomal proteins. Recent discoveries indicate cell-signalling pathway disturbance(s) either 
induced by desmosomal protein defects or by disruptions elsewhere in the pathway, as the ‘final 
common pathway’ in ARVC. We decided to initiate PLEC1 mutation analysis in a group of patients 
with ARVC and ARVC-like cardiac disease because: 1. plectin has been localized to desmosomes 
as well, 2. plectin-knockout mice show cardiac pathology, and 3. because of the findings in the 
patient described in chapter 7 (EBS-MD and cardiomyopathy with conduction disturbances due 
to PLEC1 mutations). The results will reveal whether PLEC1 mutations, in addition to hereditary 
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